Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.

Klaassen, D J

Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer. [electronic resource] - Cancer chemotherapy reports - 667-9 p. digital

Publication Type: Journal Article

0069-0112


Administration, Oral
Anemia--chemically induced
Antineoplastic Agents--administration & dosage
Cyclohexanes--administration & dosage
Drug Evaluation
Female
Gastrointestinal Neoplasms--drug therapy
Humans
Leukopenia--chemically induced
Male
Nitrosourea Compounds--administration & dosage
Thrombocytopenia--chemically induced